Eli Lilly's New Weight Loss Pill Foundayo Now Available in US
Eli Lilly launched Foundayo, a new daily weight loss pill, in the United States on Thursday. The pill is approved for adults with obesity or who are overweight with health problems.
Eli Lilly announced Thursday that Foundayo (orforglipron) is now available to buy across the United States. The FDA approved this once-daily pill for adults with obesity or those who are overweight and have weight-related health issues.
Foundayo is a GLP-1 medication, the same type of drug found in popular weight loss shots like Ozempic and Wegovy. But this version comes as a pill you take once a day instead of giving yourself weekly injections.
The monthly cost varies widely based on insurance coverage. Patients could pay anywhere from $25 to $349 per month for the medication. Insurance plans will determine the final price for most users.
This marks the first oral GLP-1 weight loss drug to hit the US market. Previous options required patients to inject themselves weekly, which some people found difficult or uncomfortable.
This gives people a pill option instead of weekly shots for weight loss treatment. The cost ranges from $25 to $349 per month depending on your insurance coverage.
Patients can now ask their doctors about Foundayo and check with insurance about coverage costs.
Was this article helpful?
0 people found this helpful